Partnership & Licensing Opportunities
We are actively presenting ErpeCream® to strategic partners at key industry conferences and through direct BD outreach. Our non-confidential deck and Phase IIb study summary are available upon request.
Distributors (Consumer Products)
For distributors and commercial partners — Products available today, registered and ready for global distribution.
Available Products
Target Channels
Benefits
Co-Development / Licensing
For pharmaceutical partners — Phase IIb in progress, ready for licensing or co-development agreements.
Current Study
Phase IIb head-to-head vs acyclovir with PPD (Thermo Fisher Scientific). 80 patients, 7 countries, 25 sites. Started January 2026. Primary readout: 7-8 months.
Partnership Options
Post-Phase IIb readout licensing for specific territories or global rights
Joint investment in pivotal Phase III program. Shared risk/reward.
Full asset or company acquisition. IP + data room available.
ACRO-EYE & Easy-Dialysis
For partners interested in ophthalmology or medical devices — Earlier-stage programs with significant market potential.
ACRO-EYE™
Tacrolimus ophthalmic solution for KCS. No direct equivalent. Co-development or licensing opportunity.
Easy-Dialysis™
Portable hemodialysis device. Prototype complete. Investment required for CE Marking.
Request Partner Deck
Complete the form to receive our non-confidential deck and Phase IIb study summary.